Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2004
10/27/2004EP1315728B1 Process for the preparation of vitronectin receptor antagonists
10/27/2004EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/27/2004EP1212269B1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
10/27/2004EP1089984B1 Non-yellowing para-tertiary-alkyl phenyl substituted triazine and pyrimidine ultraviolet light absorbers
10/27/2004CN1541259A Fluorescent diketopyrrolopyrrole analogues
10/27/2004CN1541215A HIV inhibiting pyrimidines derivatives
10/27/2004CN1541208A 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
10/27/2004CN1539828A Nitrogen-contg. heterocyclic carboxamide derivatives or salt thereof
10/27/2004CN1539827A 6-substitution-5-fluorin-4-hydroxy miazines compound and intermediate, synthetic method and usage
10/26/2004US6809202 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
10/26/2004US6809199 (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
10/26/2004US6809102 For therapy of proliferative diseases, such as cancer; to interrupt mitosis
10/26/2004US6809100 Hydroxamic acid derivatives
10/26/2004US6809093 Drug resistance therapy
10/26/2004US6809088 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
10/26/2004CA2132514C Antiproliferative quinazolines
10/21/2004WO2004089927A1 Novel methods for the treatment of inflammatory diseases
10/21/2004WO2004089914A1 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds
10/21/2004WO2004089913A1 Aminopyrimidine derivatives and their medical use
10/21/2004WO2004089905A1 N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine d3 receptor
10/21/2004WO2004089885A1 Novel compounds
10/21/2004WO2004089366A1 Bicyclic compounds as nr2b receptor antagonists
10/21/2004WO2004089286A2 Novel compounds and compositions as protein kinase inhibitors
10/21/2004WO2004065380A8 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/21/2004US20040209905 Quinoline derivatives and quinazoline derivatives
10/21/2004US20040209904 Substituted quinazoline compounds useful as P38 kinase inhibitors
10/21/2004US20040209901 substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors.
10/21/2004US20040209895 inhibit cyclin-dependent kinases and VEGF-receptor tyrosine kinases
10/21/2004US20040209865 use for reducing body weight and treating urinary incontinence; Melanin-concentrating hormone (MCH); 5-(4-chloro-phenyl)-2-[5-(2-pyrrolidin-1-yl-ethoxy)-pyridin-2-yl-ethynyl]-pyridine for example
10/21/2004US20040209799 comprises inhibitors (cytokines) of janus kinases (JAK)/signal transducers and activators of transcription (STAT) other than debromohymenialdisine and hymensialdisine; gene expression inhibition; bioassay, immunoassay, drug screening; for treatment of degenerative joint diseases such as osteoarthritis
10/21/2004US20040206270 Ink composition containing a particular type of dye, and corresponding ink-jet printing process
10/21/2004CA2521907A1 Bicyclic compounds as nr2b receptor antagonists
10/21/2004CA2521606A1 Novel methods for the treatment of inflammatory diseases
10/21/2004CA2521340A1 Aminopyrimidine derivatives and their medical use
10/21/2004CA2521184A1 Novel compounds and compositions as protein kinase inhibitors
10/20/2004EP1468990A1 Piperazine derivative
10/20/2004EP1467988A1 Quinazoline(di)ones for invertebrate pest control
10/20/2004EP1467975A1 Substituted alkyl uracils and the use thereof
10/20/2004EP1467723A1 Phenyl sulfoxides and phenyl sulfones
10/20/2004EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/20/2004CN1538994A Novel azo pigments
10/20/2004CN1171877C Method for the production of (3-chloro-4-fluoro-phenyl) amine compound
10/20/2004CN1171876C Synthesis of quinazoline-4 (3H) derivative
10/20/2004CN1171875C Uracil substituted phenyl sulfamoyl carboxamides
10/20/2004CN1171863C Carbamate derivatives and agricultural/horticulatrual bactericides
10/20/2004CN1171859C Fungicide and insecticide benzyloxycyclopropyl substituted aromatic compound fungicide
10/19/2004US6806367 Process for producing carbonyl hydrazones
10/19/2004US6806274 Quinazoline derivatives
10/19/2004US6806230 Pyrimidine derivatives and herbicides containing them
10/14/2004WO2004087680A1 Novel quinazoline derivatives and methods of treatment related to the use thereof
10/14/2004WO2004087679A1 2, 4, 6-trisubstituted pyrimidine derivatives useful for the treatment of neoplastic and autoimmune diseases
10/14/2004WO2004087678A1 2-substituted pyrimidines
10/14/2004WO2004087677A2 Pyrimidin-4-one derivatives and their use as p38 kinase modulators
10/14/2004WO2004087669A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
10/14/2004WO2004087628A1 An amino alcohol ligand and its use in preparation of chiral proparglic tertiary alkohols and tertiary amines via enantioselective additon reaction
10/14/2004WO2004087056A2 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ
10/14/2004WO2004087053A2 Dipeptidyl peptidase inhibitors
10/14/2004WO2004037176A3 Quinazolinones and derivatives thereof as factor xa inhibitors
10/14/2004WO2004000762A3 Propionic acid derivatives and their use as hppars activators
10/14/2004US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/14/2004US20040204498 Pyrimidine carboxamides; 5-hydroxy-2-(2-(1,1-Dioxo-6-[1,2]thiazinan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides; AIDS; AIDS related complex
10/14/2004US20040204422 N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
10/14/2004US20040204412 Useful as anticoagulants in therapy and prophylaxis of cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in therapy of cancer
10/14/2004US20040204409 Useful as antagonists of NMDA (N-methyl-D-aspartate) NR2B receptor; for therapy of pain, stroke, traumatic brain injury, Parkinson's disease, Alzheimer's disease, depression, anxiety, migraine
10/14/2004US20040204386 for uses such as inhibiting the activity of lysophosphatidic acid acyltransferase beta and/or inhibiting the proliferation of a cell (e.g., tumor cell)
10/14/2004US20040204347 administering an effective amount of an inhibitor of the interaction of glutamate with the alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor complex to treat demyelinating disorders
10/14/2004US20040204257 System for and a method of manufacturing personal golf putters
10/14/2004US20040200010 Dyeing keratin fibers using developer ,coupler, oxidizer
10/14/2004CA2520465A1 Bi-cyclic pyrimidine inhibitors of tgf.beta.
10/14/2004CA2518913A1 Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
10/14/2004CA2518465A1 Dipeptidyl peptidase inhibitors
10/13/2004EP1466907A1 Process for producing quinazolin-4-one and derivative thereof
10/13/2004EP1466898A1 Beta-amyloid protein production/secretion inhibitors
10/13/2004EP1466625A1 Preventives/remedies for urinary disturbance
10/13/2004EP1466607A1 Compositions for the treatment of primary and metastatic neoplastic diseases using arsenic compounds in combination with all-trans retinoic acid
10/13/2004EP1466605A2 Calcium channel blockers
10/13/2004EP1466506A1 Electroluminescent iridium compounds wiht fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
10/13/2004EP1466174A2 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571
10/13/2004EP1465878A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors
10/13/2004EP1465876A1 Long chain fatty alcohol substituents in antineoplastic agents
10/13/2004EP1465875A1 Novel alkansulfonamides as endothelin antagonists
10/13/2004EP1465862A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
10/13/2004EP1465854A2 Chalcone derivatives and their use to treat diseases
10/13/2004EP1465632A1 Quinazoline derivatives for the treatment of abnormal cell growth
10/13/2004EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
10/13/2004EP1169038A4 Cyclic protein tyrosine kinase inhibitors
10/13/2004CN1537112A Pyrimidine compound
10/13/2004CN1537105A Quinazolines as MMP-13 inhibitors
10/13/2004CN1537104A Pyrimidine derivatives useful as selective COX-2 inhibitors
10/13/2004CN1537102A Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors
10/13/2004CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators
10/13/2004CN1535958A Alpha-substituted pyrimidine. thioalkyl and alkyl ether compound
10/13/2004CN1170826C Amide compounds
10/13/2004CN1170823C [5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinyl amino] acetamide derivatives, process for producing the same, medicinal compositions the same and internediate of these compounds
10/13/2004CN1170813C N2 phenylamidine derivatives and fungicidal composition and use
10/12/2004US6803447 Preparation of supramolecular polymers by copolymerization of monomers containing quadruple hydrogen bonding units with regular monomers
10/12/2004US6803384 Diaminopropionic acid derivatives
10/12/2004US6803370 Compounds for use in the treatment of asthma, alzheimer's, diabetes, atherosclerosis, inflammatory bowel disease, arthritis, tumor metastasis, ischemia and brain disorders
10/12/2004CA2170394C Process for conditioning substances
10/07/2004WO2004085407A1 Pyrimidine compound and arthropod control agent containing the same